News

Eli Lilly’s rheumatoid arthritis medication Olumiant (baricitinib) may be the next treatment for COVID-19, thanks to AI analysis
By admin / June 29, 2020

Eli Lilly’s rheumatoid arthritis medication Olumiant (baricitinib) may be the next treatment for COVID-19, thanks to AI analysis

Eli Lilly’s rheumatoid arthritis medication, Olumiant (baricitinib), is currently in phase 3 clinical trials to become a potential drug used...

Read More
By: Samuel Won, PharmD Candidate 2021
By admin / June 29, 2020

By: Samuel Won, PharmD Candidate 2021

According to the Centers for Disease Control and Prevention (CDC), elderly patients are at increased risk of complications and death...

Read More
A Peptide to Increase Lifespan and Decrease Age-Related Diseases
By admin / June 29, 2020

A Peptide to Increase Lifespan and Decrease Age-Related Diseases

Human longevity. Long have men sought to predict or control their own lifespans or improve their vitalities. Many cultures have...

Read More
Coronavirus breakthrough: dexamethasone is first drug shown to save lives
By admin / June 20, 2020

Coronavirus breakthrough: dexamethasone is first drug shown to save lives

A breakthrough has been discovered in one of the world’s biggest randomized, controlled trials for coronavirus treatment. Based in the...

Read More
FDA Approves First Drug for Imaging Tau Pathology in Alzheimer’s Disease
By admin / June 18, 2020

FDA Approves First Drug for Imaging Tau Pathology in Alzheimer’s Disease

Tauvid (flortaucipir F18) was recently approved for intravenous injection during PET imaging of for patients being evaluated for Alzheimer’s disease...

Read More
The Effect of Personality Traits on Risk of Incident Pre‐dementia Syndromes
By admin / June 17, 2020

The Effect of Personality Traits on Risk of Incident Pre‐dementia Syndromes

An intriguing new study was published this month in The Journal of the American Geriatrics Society, proposing that personality traits...

Read More
This Just In: FDA Approves Antibiotic to Treat Hospital-Acquired (HAP) and Ventilator-Acquired (VAP) Bacterial Pneumonia
By admin / June 17, 2020

This Just In: FDA Approves Antibiotic to Treat Hospital-Acquired (HAP) and Ventilator-Acquired (VAP) Bacterial Pneumonia

On June 4th, 2020 the FDA approved Recarbrio (imipenem-cilastatin and relebactam) to treat HAP/VAP in patients over 18 years old....

Read More
By admin / June 2, 2020

CMS Guidelines for Nursing Home Visits Post-COVID

It goes without saying that patients at nursing homes and other long term care facilities are at the most risk...

Read More
FDA Authorizes First Standalone At-Home Sample Collection Kit for COVID-19 Diagnostic Testing
By admin / June 2, 2020

FDA Authorizes First Standalone At-Home Sample Collection Kit for COVID-19 Diagnostic Testing

The FDA has officially authorized the first at-home sample collection kit that can be sent off to two different laboratories...

Read More
By admin / May 21, 2020

Arthritis and its Connection to Cardiovascular Disease

Of people aged 65 years or older, 49.6% have reported doctor-diagnosed arthritis according to a 2015 national survey conducted by...

Read More
Scroll to Top